| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.738 | 14.497 | 15.361 | 14.646 | 14.377 | 14.309 | 18.935 | 22.403 | 28.746 | 32.853 |
| Total Income - EUR | 15.854 | 14.499 | 15.361 | 14.646 | 14.563 | 14.309 | 18.935 | 22.403 | 28.746 | 32.853 |
| Total Expenses - EUR | 9.817 | 3.970 | 4.508 | 5.729 | 4.928 | 2.330 | 4.673 | 9.088 | 12.261 | 11.987 |
| Gross Profit/Loss - EUR | 6.037 | 10.530 | 10.853 | 8.917 | 9.635 | 11.979 | 14.262 | 13.315 | 16.484 | 20.866 |
| Net Profit/Loss - EUR | 5.562 | 10.095 | 10.392 | 8.478 | 9.198 | 11.589 | 13.695 | 12.911 | 16.202 | 20.028 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Speranta Bioxim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.816 | 21.406 | 20.860 | 20.296 | 19.726 | 19.178 | 18.583 | 18.469 | 18.243 | 17.972 |
| Current Assets | 5.081 | 11.112 | 8.611 | 8.659 | 7.611 | 10.981 | 14.615 | 24.022 | 37.592 | 41.117 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.784 | 1.748 | 1.917 | 1.840 | 1.996 | 1.968 | 2.048 | 2.431 | 2.754 | 4.224 |
| Cash | 3.297 | 9.363 | 6.694 | 6.819 | 5.615 | 9.012 | 12.567 | 21.591 | 34.838 | 36.893 |
| Shareholders Funds | -93.712 | -82.662 | -70.871 | -61.093 | -50.711 | -38.161 | -23.621 | -10.783 | 5.452 | 25.450 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 120.858 | 115.179 | 100.341 | 90.048 | 78.048 | 68.319 | 56.818 | 53.274 | 50.574 | 33.829 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Speranta Bioxim Srl